Lorica Pharmaceuticals Limited
About Lorica Pharmaceuticals Limited
Data last updated:
Lorica Pharmaceuticals Limited is a public limited company based in Badaun, Uttar Pradesh, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 08 June 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U36912UP2009PLC037548. Its GSTIN is 09AABCL6234B1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Alok Sinha (Managing Director) and Nisha Rathore.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 86 Brahampura, Badaun, Uttar Pradesh, India – 243601.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.09 Lakh, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹5,930 (net margin 0.1%) and EBITDA of ₹1.39 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lorica Pharmaceuticals Limited's registered office is in Badaun, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address86 Brahampura, Badaun, Uttar Pradesh, India – 243601
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Lorica Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lorica Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lorica Pharmaceuticals Limited, buy the company report.
Financials of Lorica Pharmaceuticals Limited
FY 2025 filings availableLorica Pharmaceuticals Limited reported revenue of ₹50.09 Lakh (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,930 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lorica Pharmaceuticals Limited, buy the company report.
Board of directors of Lorica Pharmaceuticals Limited
Lorica Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alok Sinha | Managing Director | 08 Jun 2009 | 17 Years 4 Months | Current |
| Nisha Rathore | Director | 08 Jun 2009 | 17 Years 4 Months | Current |
| Virendra Singh Pal | Director | 08 Jun 2009 | 17 Years 4 Months | Current |
Peer comparison
Lorica Pharmaceuticals Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lucan Pharmaceuticals Private Limited | ₹50.57 Lakh (FY 2023) | 114.0% | Delhi, India | |||
| Azott Pharmaceuticals Private Limited | ₹50.53 Lakh (FY 2021) | -30.0% | Saraikela, Jharkhand, India | |||
| Provatas Pharmaceuticals Private Limited | ₹50.2 Lakh (FY 2025) | 35.0% | Delhi, India | |||
| Lorica Pharmaceuticals Limitedthis company | ₹50.09 Lakh (FY 2025) | ₹5,930 | 0.1% | -13.0% | Badaun, Uttar Pradesh, India | |
| Weizman Pharmaceuticals Private Limited | ₹49.87 Lakh (FY 2025) | 5.0% | Bahraich, Uttar Pradesh, India | |||
| Curenetic Pharmaceuticals Private Limited | ₹49.82 Lakh (FY 2025) | 8.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Lorica Pharmaceuticals Limited, buy the company report.
Auditor
Lorica Pharmaceuticals Limited is audited by AGARWALURS & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWALURS & CO. | FY 2017 | 013910C |
Shareholding
The shareholding of Lorica Pharmaceuticals Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Lorica Pharmaceuticals Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lorica Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lorica Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lorica Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCL6234B1ZU | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lorica Pharmaceuticals Limited, buy the company report.
Recent activity
Lorica Pharmaceuticals Limited has 3 board changes on record since 2009: 3 appointments. The latest: Alok Sinha was appointed as Managing Director on 08 Jun 2009.
Frequently asked questions
Lorica Pharmaceuticals is an active public limited company based in Badaun, Uttar Pradesh, India. The company works in retailers, within the trading industry. It was incorporated on 08 June 2009 (17+ years old) and is registered under CIN U36912UP2009PLC037548.
Lorica Pharmaceuticals has 3 current directors:
- Alok Sinha - Managing Director
- Nisha Rathore - Director
- Virendra Singh Pal - Director
The latest financial statements of Lorica Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lorica Pharmaceuticals is 09AABCL6234B1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Lorica Pharmaceuticals is U36912UP2009PLC037548. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lorica Pharmaceuticals was incorporated on 08 June 2009, making it 17+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Lorica Pharmaceuticals by revenue are Lucan Pharmaceuticals Private Limited, Azott Pharmaceuticals Private Limited, Provatas Pharmaceuticals Private Limited, Weizman Pharmaceuticals Private Limited, Curenetic Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Alok Sinha was appointed as Managing Director on 08 Jun 2009. Nisha Rathore was appointed as Director on 08 Jun 2009. Virendra Singh Pal was appointed as Director on 08 Jun 2009.
The registered office of Lorica Pharmaceuticals is at 86 Brahampura, Badaun, Uttar Pradesh, India – 243601.
Lorica Pharmaceuticals operates in the trading industry, in the retailers segment.
The compliance status of Lorica Pharmaceuticals is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
